Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
1 other identifier
observational
2,000
1 country
1
Brief Summary
The goal of this study is to obtain specimens and data from individuals and their families with heterotaxy and related congenital heart defects in order to clarify the molecular genetics of this disorder. The knowledge gained from the analysis of this information will provide the basis for future genetic counseling as well as contribute to knowledge about the biology of normal and abnormal development of left-right anatomic asymmetry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 28, 2015
CompletedFirst Posted
Study publicly available on registry
May 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
June 26, 2025
June 1, 2025
21.4 years
April 28, 2015
June 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clarify Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
These results will provide important information on the causes, management, and prognosis of heterotaxy and related congenital heart defects. This will provide the basis for future genetic testing and genetic counseling as well as contribute to knowledge about the biology of normal and abnormal development of left-right asymmetry.
8 years
Study Arms (1)
Heterotaxy and congenital heart defects
Patients and family members with heterotaxy and related congenital heart defects
Eligibility Criteria
children affected with heterotaxy syndrome and/or congenital heart defects and their relatives
You may qualify if:
- Subjects with heterotaxy and related congenital heart defects
- Family members of subjects with heterotaxy and related congenital heart defects
You may not qualify if:
- Subjects without heterotaxy and related congenital heart defects
- Family members of subjects without heterotaxy and related congenital heart defects
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Indiana University School of Medicine
Indianapolis, Indiana, 46202, United States
Biospecimen
Whole Blood, Tissue Sample, Cheek Swabs, Saliva
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephanie M. Ware, MD, PhD
Indiana University School of Medicine
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pediatrics and Medical and Molecular Genetics
Study Record Dates
First Submitted
April 28, 2015
First Posted
May 1, 2015
Study Start
July 1, 2009
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
December 1, 2030
Last Updated
June 26, 2025
Record last verified: 2025-06